Background
==========

An overview of the diabetes mellitus (DM) prevalence in Tunisia shows that it corresponds to 9.3--11.0% (between 2010 and 2030), which is in accordance with the percentage observed in other countries. The world prevalence of diabetes among adults (aged 20--79 years) is 6.4%, corresponding to 285 million, in 2010, and will be estimated by 7.7%, equivalent to 439 million, by 2030. In fact, it is one of the most common chronic diseases in nearly all countries, and continues to increase in number and significance due to the changing lifestyles that lead to the reduction of physical activity and increase of obesity \[[@B1]\].

Numerous studies have demonstrated that oxidative stress, mediated mainly by hyperglycemia-induced generation of free radicals, contributes to the development and progression of diabetes and its complications \[[@B2]-[@B4]\]. The abnormally high level of free radicals leads to membrane damage because of membrane lipids peroxidation, protein glycation and the simultaneous decline of antioxidant defense mechanisms \[[@B4],[@B5]\]. Nowadays, although the major agents used for diabetes treatment are synthetic drugs and insulin, they usually come with considerable side effects, such as hypoglycemia, drug-resistance, dropsy, and weight gain \[[@B6]\]. However, as hundreds of traditional folk medicines have proven to be efficient for the treatment of diabetes with less tolerability and side effects, there is an increasing trend towards searching for more natural antidiabetic agents.

Rose-scented geranium is an important aromatic plant that grows in temperate areas of the world \[[@B7]\] including those in Tunisia. Geranium oil has a fine rosy odor with pronounced fruity minty undertone and a rich long-lasting sweet-rosy dryout \[[@B8]\]. As the cost of its highly valued essential oil, which is used in soaps, perfumery, and cosmetic industries, is increasing in international market, attempts were made to promote its cultivation by employing various agrotechnologies \[[@B9]\].

The essential oil of *P. graveolens* has been used for many years in traditional medicine as antiasthmatic, antiallergic, antioxidant, antidiarrhoeic, antihepatotoxic, diuretic, tonic, haemostatic, stomachic and diabetic \[[@B10]-[@B14]\].

It is worthwhile to note that no detailed studies have been carried out on the efficiency of *Pelargonium graveolens* in the modulation of oxidative stress pertaining to DM in experimental animals. Hence, the present study undertakes the investigation of possible hypoglycemic and antioxidant effects of *Pelargonium graveolens* leaves in alloxan-induced diabetic rats. Indeed, the essential oil of rose-scented geranium leaves was prepared and their antioxidant activities as well as their hypoglycemic effects were studied.

Results
=======

Chemical constitution of leaf essential oil
-------------------------------------------

The hydrodistillation of the leaves of *P. graveolens* generated pale yellow coloured oil (yield of 0.19%, v/w). Upon GC/MS analysis, the essential oil was found to contain 47 constituents, 96.23% of which were identified (Table [1](#T1){ref-type="table"}). All constituents were eluted between 8 and 31 min. The volatile oil contained 67.39% monoterpenoids, 25.4% sesquiterpenoids, and 3.44 other compounds. The major components were β-citronellol (16.24%) followed by geraniol (15.30%), δ-selinene (8.69%), citronellyl formate (7.39%), geranyl formate (6.47%), l-menthone (4.13%) and linalool-l (3.8%). Twenty nine components of the oil amounted to \<1%.

###### 

**Chemical composition of leaf essential oil of*Pelargonium graveolens*L'Hér**

  **N°**   **Composant**                 **RT**   **KI**^**a**^   **%**
  -------- ----------------------------- -------- --------------- -------
  1        α-pinene                      8.870    930             0.66
  2        β-myrcene                     10.633   997             0.18
  3        phellandrene                  10.010   1007            0.09
  4        β-phellandrene                11.766   1023            0.21
  5        cis-ocimene                   12.063   1030            0.16
  6        β-ocimene                     12.378   1037            0.13
  7        linalool l                    14.003   1073            3.80
  8        rose oxide-trans              14.772   1079            0.54
  9        l-menthone                    15.908   1141            4.13
  10       3-p-menthanol                 16.418   1186            0.14
  11       α-terpineol                   16.646   1197            0.24
  12       β-citronellol                 17.894   1237            16.24
  13       z-citral                      18.106   1244            0.71
  14       nerol                         18.495   1259            3.08
  15       geraniol                      18.706   1266            15.30
  16       e-citral                      18.981   1277            0.84
  17       citronellyl formate           19.113   1282            7.39
  18       geraniol formate              19.834   1309            6.47
  19       propanoic acid                21.087   1357            0.39
  20       lavandulyl acetate            21.893   1388            0.76
  21       β-bourbonene                  22.014   1393            1.01
  22       trans-caryophyllene           22.912   1427            1.63
  23       β-cubebene                    23.129   1434            0.64
  24       citronellyl propionate        23.393   1444            0.14
  25       azulene                       23.473   1449            0.40
  26       α-cubebene                    23.662   1458            0.96
  27       α-humulene                    23.759   1460            0.51
  28       aromadendrene                 23.942   1467            0.68
  29       germacrene-d                  24.457   1486            2.87
  30       β-selinene                    24.577   1492            0.17
  31       β-cuvebene                    24.709   1496            0.32
  32       ledene                        24.806   1500            3.10
  33       α-muurolene                   24.880   1504            0.18
  34       elemol                        25.029   1510            0.40
  35       α-amorphene                   25.229   1519            0.29
  36       δ-cadinene                    25.447   1528            1.36
  37       epizonaren                    25.504   1530            0.24
  38       α-gurjunene                   25.790   1545            0.55
  39       α-agarofuran                  26.030   1553            0.57
  40       neryl acetate                 26.236   1563            1.06
  41       phenylethyl tiglate           26.894   1591            2.07
  42       δ-selinene                    27.816   1631            8.69
  43       agarospirol                   28.090   1643            0.46
  44       isoledene                     28.474   1660            1.18
  45       propanoate                    28.657   1667            0.43
  46       geranyl tiglate               29.475   1703            3.05
  47       mintsulfide                   30.373   1746            1.81
           Total                         96.23                    
           Monoterpenes hydrocarbons     1.43                     
           Oxygenated monoterpenes       65.96                    
           Sesquiterpenes hydrocarbons   24.54                    
           Oxygenated sesquiterpenes     0.86                     
           Other compounds               3.44                     

^a^ KI, retention index (Kovalts) relative to *n*-alkanes (C9--C26) on a polar DB-5 MS column.

Body weight
-----------

Table [2](#T2){ref-type="table"} shows the body weight in normal and experimental animals in each group. Indeed, the injection of alloxan (150 mg/kg) reduced the body weight of diabetic rats compared with controls. The mean body weight of diabetic rats showed a decrease by 19.74% compared with normal animals. The body weight of diabetic rats treated with essential oil significantly increased as compared with non-treated diabetic animals.

###### 

Growth Performance of the experimental Rats\*

  **Groups**                       **Initial body wt (g)**   **Final body wt (g)**
  -------------------------------- ------------------------- -----------------------
  Control                          230.16 ± 5.55 ^a^         318.24 ± 9.12 ^a^
  Diabetic                         225.87 ± 7.94 ^a^         255.39 ± 11.89 ^b^
  Glibenclamide (600 μg/kg b.w.)   227.97 ± 6.20 ^a^         277.17 ± 10.23 ^c^
  EO 1 (75 mg/kg b.w.)             228.22 ± 6.32 ^a^         280.09 ± 7.66 ^c^
  EO 2 (150 mg/kg b.w.)            230.11 ± 5.96 ^a^         301.83 ± 10.54 ^d^

^abcd^ The means in the row not sharing a common letter are significantly different among groups (*p* \< 0.05).

\* Values are expressed as means ± S.E. (n = 8).

Serum glucose and hepatic glycogen concentration
------------------------------------------------

The serum glucose levels of diabetic rats were significantly higher compared with those of the control group (*p* \< 0.05) (Figure [1](#F1){ref-type="fig"}). After the administration of the leaf essential oil of *P. graveolens*, a significant decrease in blood glucose was observed compared with that of the diabetic group (*p* \< 0.05) (Figure [2](#F2){ref-type="fig"}). Moreover, rats receiving essential oil at 150 mg/kg b.w. illustrated a significantly pronounced antidiabetic effect compared with those receiving these compounds at 75 mg/kg b.w. However, the hepatic glycogen levels showed a significant decrease by 86.56% in diabetic rats compared with those in the controls (Figure [1](#F1){ref-type="fig"}). Furthermore, all of the groups receiving the two doses of essential oil of *P. graveolens* depicted a significant increase in glycogen levels compared with those of the normal and with the diabetic controls. The rats receiving essential oil at 150 mg/kg b.w. showed the significantly highest levels of hepatic glycogen concentration (*p* \< 0.05).

![**Effects of leaf essential oil (EO1 and EO2) and glibenclamide on serum glucose levels and liver glycogen levels in normal and alloxan-induced diabetic male wistar rats for 30 days.** Values are expressed as means ± S.E. (n = 8).^abcd^ The means not sharing a common letter are significantly different among groups (*p* \< 0.05).](1476-511X-11-81-1){#F1}

![**Effects of leaf essential oil (EO1 and EO2) on blood glucose levels in normal and alloxan-induced diabetic male wistar rats for 30 days.** Values are expressed as means ± S.E. (n = 8). Values differ significantly at *p* \< 0.05.](1476-511X-11-81-2){#F2}

Hepatic function, diabetes and *P. graveolens* preparations
-----------------------------------------------------------

This study has demonstrated a decrease in the SOD (superoxide dismutase), CAT (catalase) and GPX (glutathione peroxidase) activities in hepatic tissues of diabetic rats together with an increase in plasma TBARS levels (Figure [3](#F3){ref-type="fig"}). In diabetic rats treated with two doses of essential oil, a clear protective effect was observed in hepatic function and metabolism. In fact, the administration of glibenclamide inhibited all changes caused by alloxan-induced diabetes. This positive effect of the essential oil was confirmed by histological findings (Figure [4](#F4){ref-type="fig"}). As shown in Figure [4](#F4){ref-type="fig"}B, vacuolated hepatocytes with the nucleus being pushed to the periphery and fatty cyst were observed in diabetic rats. This structure is different compared with the livers of normal control rats. However, the essential oil administration to diabetic rats reduced the appearance of fat cells in liver (Figure [4](#F4){ref-type="fig"}D).

![**Effects of leaf essential oil (EO1 and EO2) and Glibenclamide on hepatic SOD, CAT, GPX activities and TBARS of diabetic male wistar rats for 30 days.** Values are expressed as means ± S.E. (n = 8). ^abcd^ The means not sharing a common letter are significantly different among groups (*p* \< 0.05).](1476-511X-11-81-3){#F3}

![**(A) Normal rat liver.** (**B**) Diabetic rat liver: sinusoidal congestion and fatty degeneration in the form of fat lake. (**C**) Diabetic rat treated with Glibeclemide and (**D**) Diabetic rat treated with essential oil (150 mg/kg): a positive effect was observed (H&E 100×).](1476-511X-11-81-4){#F4}

Renal function, diabetes and *P. graveolens* preparations
---------------------------------------------------------

In diabetic rats, a decrease in the SOD, CAT and GPX activities by 43.8, 35.7 and 42.12%, respectively, in kidneys was shown at the end of the experiment, Moreover, a significant increase of TBARS in kidneys by 37.39% was obtained in alloxan-treated rats (Figure [5](#F5){ref-type="fig"}). However, after the essential oil administration, a positive action from nephropathy was clearly observed. In fact the renal SOD, CAT and GPX antioxidant activities increased after the administration of essential oil at 150 mg/kg b.w. Furthermore, the *P. graveolens* oils decreased lipid peroxidation content. Moreover, a normal histological structure was observed (Figure [6](#F6){ref-type="fig"}A). This positive effect of these fractions was confirmed by histological findings. As shown in Figure [6](#F6){ref-type="fig"}B, although fatty infiltration was found in the kidneys of diabetic rats, the structure of the glomeruli remained intact in the kidneys of the rats treated with essential oil (Figure [6](#F6){ref-type="fig"}C, Figure [6](#F6){ref-type="fig"}D), which is very near to the control rat kidney histological organisation.

![**Effects of leaf essential oil (EO1 and EO2) and Glibenclamide on SOD, CAT, GPX activities and TBARS in kidney of diabetic male wistar rats for 30 days.** Values are expressed as means ± S.E. (n = 8). ^abcd^ The means not sharing a common letter are significantly different among groups (*p* \< 0.05).](1476-511X-11-81-5){#F5}

![**(A) Normal rat kidney.** (**B**) Diabetic treated rat kidney: tubular epithelial damage messangial capillary proliferation and fatty infiltration. (**C**) Diabetic rat treated with Glibeclemide and (**D**) Diabetic rat treated with essential oil (150 mg/kg): a positive effect was observed (H&E 100×).](1476-511X-11-81-6){#F6}

Discussion
==========

Diabetes mellitus, a leading metabolic disorder worldwide, is characterized by hyperglycemia associated with impairment in insulin secretion and/or insulin action as well as alteration in intermediary metabolism of carbohydrate, protein and lipids. Reactive oxygen species play a relevant role in the etiology and pathogenesis of diabetes mellitus and its complications. Lipid peroxide mediated tissue damage has been demonstrated in insulin dependent and non-insulin-dependent diabetes mellitus \[[@B15]\]. As a strategy to counteract the negative effect of oxidative stress, antioxidant-based therapy is promising to minimize the complications in diabetes mellitus. The present study was undertaken to evaluate the hypoglycemic and antioxidant status of leaf essential oil of *P. graveolens* on alloxan induced diabetes. To the best of our knowledge, this is the first report of hypoglycemic activity of this plant. Our results have proved that the leaf essential oil at two different doses, 75 and 150 mg/kg b.w., had significant hypoglycemic and antioxidant effects comparable to those of glibenclamide. It has been reported that glibenclamide produces the hypoglycemic effect by stimulating insulin secretion from β cells of pancreatic islets \[[@B16],[@B17]\]. In the present study, the oral administration of the essential oil of *P. graveolens* brought about significant hypoglycemic effects in alloxan-induced diabetic rats, mainly at 150 mg/kg b.w. The eventual mechanism responsible for the hypoglycemic effect of this plant may result from a potentiation of glucose-induced insulin release or increased peripheral uptake of glucose \[[@B18]\]. In fact, the hepatic glycogen levels in diabetic rats receiving essential oil were significantly higher than those of the normal as well as diabetic rats. The hypoglycemic effect of *P. graveolens* essential oil extract is probably related to its content of several bioactive antidiabetic principles. In addition, the antidiabetic effect of monoterpenes which were the major compounds identified in *Satureja khozestanica* essential oil, was previously demonstrated by Tavafi et al. \[[@B16]\].

Several studies have illustrated the increased lipid peroxidation in clinical and experimental diabetes. It has been established that diabetes leads to increased production of oxygen free radicals \[[@B19],[@B20]\] which exert their cytotoxic effect by causing lipid peroxidation, resulting in the formation of TBARS. In our study, alloxan-induced diabetic rats showed a significant rise in liver and kidney TBARS levels. The treatment of diabetic rats with the leaf essential oil of *P. graveolens* has confirmed significant reduction of TBARS in all analyzed tissues. These data suggest that rats treated with *P. graveolens* oil are less susceptible to peroxidative damage under the challenge of oxidative stress such as diabetes.

It has also been reported that oxidative stress may constitute the key and common event in the pathogenesis of different diabetic complications \[[@B21]\]. This stress results from an imbalance between the production of free radicals and the effectiveness of the antioxidant defence system \[[@B22]\]. Dietary monoterpenes appear to have physiological antioxidant properties, which quench reactive oxygen and nitrogen species, thereby potentially contributing against the pathogenesis of diabetic complications \[[@B16],[@B23]\]. In the present study, we have observed decreased activities of antioxidant enzymes CAT, SOD and GPX in the liver and kidneys of diabetic group. Our results are in harmony with those obtained in previous studies, which suggests that hyperglycemia induces a depletion of the antioxidant system due to the increased lipid peroxidation and formation of free radicals \[[@B24]-[@B26]\]. The treatment of alloxan-induced diabetic rats with the leaf essential oil of rose-scented geranium was confirmed to increase the SOD, CAT and GPX activities. The increase may be due to the activation of enzymes by *P. graveolens* essential oil, resulting in a lower superoxide anion level. Besides, the higher CAT, SOD and GPX activity could lead to a reduced reactive oxygen species level in *P. graveolens* oil supplemented group. These results suggest that *P. graveolens* oils reduce oxidative stress by preventing the generation of free radicals and, thus inhibiting the development of diabetes. The reduced oxidative stress and lipid peroxidation observed in the geranium essential oils treated animals may be attributed to the important role of the essential oil as antioxidants. This power may be attributed to their ability to decompose free radicals by quenching reactive oxygen species and trapping radicals before reaching their cellular targets \[[@B27]\]. The antioxidant activity of geranium essential oil could also be assigned to the presence of monoterpenes. The geraniol and β-citronellol were the major monoterpenes detected in the chemical composition of geranium oils (Table [1](#T1){ref-type="table"}). Indeed, Singh et al. \[[@B28]\] assessed the antioxidant and radical scavenging activity of two major monoterpenes (citronellal and β-citronellol) present in the essential oil of *Artemisia scoparia*. Moreover, the measured antioxidant activities could be due to the synergistic effects of two or more compounds present in the oils. In this context, Lu and Foo and Nivitabishekam et al. \[[@B29],[@B30]\] reported that most natural antioxidative compounds often work synergistically with each other to produce a broad spectrum of antioxidative properties that create an effective defence system against free radicals.

In Conclusion, the present study clearly demonstrates that the essential oil of *Pelargonium graveolens* not only exhibit a pronounced hypoglycemic effect but also reduce the lipid peroxidation process as well as enhance the antioxidant defence system. For further studies, isolation and investigation of the chemical constituent of the essential oil of *P. graveolens* responsible for the hypoglycemic effect should be undertaken in order to confirm and clarify the mechanism behind this activity.

Materials and methods
=====================

Chemicals and reagents
----------------------

Alloxan, catalase, superoxide dismutase (SOD) were purchased from Sigma-Aldrich Chemicals Pvt. Ltd., Bangalore. Serum and hepatic glucose levels were measured using commercial kits from Sigma-Aldrich (Munich, Germany). BCA protein kit was procured from Thermo Fisher Scientific Inc., MA, USA. All other chemicals and reagents used in this study were of analytical grade.

Plant material
--------------

Fresh leaves of *P. graveolens* at flowering stage were collected in March 2008 in Sfax, South-East of Tunisia (34° 47′ 57.04″ N, 10° 45′ 57.89″ E, Altitude 20 m), which is characterized by its arid climate having a mean rainfall of 200 mm per year. The leaves were manually separated and dried in the shade. Then the botanical identification of *P. graveolens* was conducted by Professor Makki Boukhris, botanist in the Faculty of Science of Sfax, Tunisia. Voucher specimens were deposited at the laboratory of Environmental bioprocesses (PG 22), in the Centre of Biotechnology of Sfax.

Essential oil isolation
-----------------------

Fresh leaves of *P. graveolens* (600 g) were separately grounded and submitted to hydrodistillation for 4 h using a clevenger-type apparatus and the obtained oil was dried over anhydrous sodium sulfate. The essential oil from leaves has a yield of 0.19% on a dry basis.

Gas chromatography/mass spectrometry (GC/MS) analysis
-----------------------------------------------------

The gas chromatography/mass spectrometry (GC/MS) analysis of the essential oil was performed using Agilent 6890 N Network gas chromatographic (GC) system equipped with a flame ionization detector. In fact, an aliquot of 1 μl of the essential oil was injected splitlessly into the GC/MS. The samples were diffused in a 30 m-long 0.25 mm i.d. and 0.25 μm-thick DB-5MS column (Agilent Technologies, J&W Scientific Products, USA) and the carrier gas used was helium. The GC oven temperature started at 100 °C and held for 1 min at 260 °C and then for 10 min with 4 °C min^−1^ program rate. While the injector and detector temperatures were set at 250 and 230 °C, respectively, the mass range was scanned from 50 to 550 amu. As for the control of the GC/MS system and the data peak processing, they were conducted by means of MSDCHEM software. With regard to the identification of components, it was realized via the comparison of the retention indices (RI) pertaining to C9--C26 *n*-alkanes and MS corresponding database (Wiley and NIST library) with the mass spectral literature.

Animals
-------

Male Wistar rats with body weights of 220 ± 10 g, were purchased from the Central Pharmacy (SIPHAT, Tunisia). They were fed on a pellet diet (SICO, Sfax, Tunisia) and water ad libitum. They were also maintained in a controlled environment under standard conditions of temperature and humidity with an alternating light-and-dark cycle (12 h day/12 h night). According to the European convention for the protection of vertebrate animals used for experimental and other scientific purposes (Council of Europe N^o^ 123, Strasbourg, 1985) and the ethics committee for research on laboratory animal use of our institution, rats rearing and experiments of this study were approved.

Experimental induction of diabetes and treatments
-------------------------------------------------

The method of diabetes induction in rats by alloxan was the same as described by Ananthan et al. \[[@B14]\]. Actually, rats were single injected intraperitoneally with a freshly prepared solution of alloxan monohydrate in normal saline at a dose of 150 mg/kg b.w., freshly dissolved in NaCl 0.9% buffer (pH 7). Since alloxan is capable of producing fatal hypoglycemia because of massive pancreatic insulin release, rats were orally treated with 20% glucose solution 6 h after the injections. The rats were then kept for the next 24 h on 5% glucose solution bottles in their cages to prevent hypoglycemia. After 2 weeks, rats with blood glucose level of above (10 mmol /dm^3^) were considered to be diabetic and used for the studies. The rats were randomly divided into five experimental groups (n = 8). Group 1 (C): normal rats. Group 2 (D): diabetic rats (glycemia was more than 10 mmol /dm^3^). Groups 3: diabetic rats treated with Glibenclamide (600 μg/kg.b.w.). Groups 4--5 (EO1 and EO2): diabetic rats orally receiving daily leaf essential oil of *P. graveolens* at 75 mg/ kg and 150 mg/kg respectively.

After one month of treatment, the animals were sacrificed by decapitation, and the trunk blood was collected. Then, the serum was prepared by centrifugation (1500 × g, 15 min, 4 °C). Next, the kidneys and liver were removed, cleaned of fat and stored at −80 °C until future use. Immediately, pieces of liver and kidney were fixed in a Bouin solution for histological studies.

Analytical methods
------------------

The activity of superoxide dismutase was examined by the spectrophotometric method of Marklund and Marklund \[[@B31]\]. Concerning the catalase (CAT), it was assayed colorimetrically at 240 nm and expressed as moles of H~2~O~2~ consumed per minute per milligram of protein, as described by Regoli and Principato \[[@B32]\]. As for the glutathione peroxidise (GPX) activity, it was measured by the method described by Pagila and Valentine \[[@B33]\]. With regard to the lipid peroxidation in the liver and kidneys of control and all treated groups, it was measured by the quantification of thiobarbituric acid-reactive substances (TBARS) determined by the method of Park et al. \[[@B34]\]. Regarding the level of total protein, it was determined referring to Lowry et al. \[[@B35]\] using bovine serum albumin as the standard at 660 nm. Furthermore, serum and hepatic glucose levels were measured using commercial kits from Sigma Munich (Munich, Germany). The Fasting blood glucose was estimated by commercially available glucose strips (Accu-Chek Active) using One Touch Glucometer (Johnson-Johnson). For histological studies, pieces of liver and kidney were fixed in a Bouin solution for 24 h, and then embedded in paraffin. 5 μm-thick sections were stained with hematoxylin-eosin and examined under the Olympus DP-70 light microscope.

Statistical analysis
--------------------

All data are presented as the mean ± SE values. The data were evaluated by a one-way analysis of variance using SPSS (Chicago, IL) software and differences between the means were determined using Student's t-test. Values were considered statistically significant when *p* \< 0.05.
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